Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Rostoker

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Seminars in Dialysis|June 30, 2018
When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?Guy Rostoker
Nephrologie & Therapeutique|July 24, 2010
[Short-term single-needle hemodialysis on native fistulae: a general review]Guy Rostoker
Nephrologie & Therapeutique|October 27, 2015
[Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice]Jacques Rottembourg, Guy Rostoker
Presse Medicale (Paris, France : 1983)|March 21, 2018
[The use of generics in transplantation: Towards rational and safe solutions!]Jacques Rottembourg, Guy Rostoker
Nephrologie & Therapeutique|April 16, 2018
[The reality on peritoneal dialysis in France: 40years after]Jacques Rottembourg, Guy Rostoker
Journal of Computer Assisted Tomography|September 18, 2014
Magnetic resonance imaging repercussions of intravenous iron products used for iron-deficiency anemia and dialysis-associated anemiaGuy Rostoker, Yves Cohen
Hemodialysis International. International Symposium on Home Hemodialysis|March 24, 2017
Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for cautionGuy Rostoker, Nosratola D Vaziri
Presse Medicale (Paris, France : 1983)|November 21, 2017
Iatrogenic iron overload and its potential consequences in patients on hemodialysisGuy Rostoker, Nosratola D Vaziri
Heliyon|July 25, 2019
Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populationsGuy Rostoker, Nosratola D Vaziri
Renal Failure|June 15, 2006
Candesartan cilexetil on regular hemodialysis: inability to reduce excessive thirst, but good tolerance and efficacy in hypertensive patientsGuy Rostoker, Mireille Griuncelli, Abbes Benmaadi
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Seminars in Dialysis|June 30, 2018
When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?Guy Rostoker
Nephrologie & Therapeutique|July 24, 2010
[Short-term single-needle hemodialysis on native fistulae: a general review]Guy Rostoker
Nephrologie & Therapeutique|October 27, 2015
[Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice]Jacques Rottembourg, Guy Rostoker
Presse Medicale (Paris, France : 1983)|March 21, 2018
[The use of generics in transplantation: Towards rational and safe solutions!]Jacques Rottembourg, Guy Rostoker
Nephrologie & Therapeutique|April 16, 2018
[The reality on peritoneal dialysis in France: 40years after]Jacques Rottembourg, Guy Rostoker
Journal of Computer Assisted Tomography|September 18, 2014
Magnetic resonance imaging repercussions of intravenous iron products used for iron-deficiency anemia and dialysis-associated anemiaGuy Rostoker, Yves Cohen
Hemodialysis International. International Symposium on Home Hemodialysis|March 24, 2017
Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for cautionGuy Rostoker, Nosratola D Vaziri
Presse Medicale (Paris, France : 1983)|November 21, 2017
Iatrogenic iron overload and its potential consequences in patients on hemodialysisGuy Rostoker, Nosratola D Vaziri
Heliyon|July 25, 2019
Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populationsGuy Rostoker, Nosratola D Vaziri
Renal Failure|June 15, 2006
Candesartan cilexetil on regular hemodialysis: inability to reduce excessive thirst, but good tolerance and efficacy in hypertensive patientsGuy Rostoker, Mireille Griuncelli, Abbes Benmaadi
Pageof 5